125 related articles for article (PubMed ID: 24197723)
21. Recurrent benign pleomorphic adenoma of the parotid gland: Facial nerve identification and risk factors for facial nerve paralysis at re-operation.
Kuriyama T; Kawata R; Higashino M; Nishikawa S; Inui T; Terada T; Haginomori SI; Kurisu Y; Hirose Y
Auris Nasus Larynx; 2019 Oct; 46(5):779-784. PubMed ID: 30922530
[TBL] [Abstract][Full Text] [Related]
22. Carcinoma in pleomorphic adenoma of the parotid gland.
Eneroth CM; Blanck C; Jakobsson PA
Acta Otolaryngol; 1968 Dec; 66(6):477-92. PubMed ID: 4308066
[No Abstract] [Full Text] [Related]
23. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.
Soares AB; Altemani A; de Araújo VC
J Oral Pathol Med; 2011 Apr; 40(4):352-8. PubMed ID: 20969626
[TBL] [Abstract][Full Text] [Related]
24. A case of pleomorphic adenoma of the parotid gland metastasizing to a mediastinal lymph node.
Steele NP; Wenig BM; Sessions RB
Am J Otolaryngol; 2007; 28(2):130-3. PubMed ID: 17362821
[TBL] [Abstract][Full Text] [Related]
25. Recurrent pleomorphic adenoma of the parotid gland in pediatric and adult patients: value of multiple lesions as a diagnostic indicator.
Koral K; Sayre J; Bhuta S; Abemayor E; Lufkin R
AJR Am J Roentgenol; 2003 Apr; 180(4):1171-4. PubMed ID: 12646477
[TBL] [Abstract][Full Text] [Related]
26. Unusual multiple metastases from malignant pleomorphic adenoma of the parotid gland.
Cherian T; Sebastian P; Abraham EK; Ahmed IM; Jayakumar KL; Sivaramakrishnan P
J Laryngol Otol; 1992 Jul; 106(7):652-5. PubMed ID: 1326589
[TBL] [Abstract][Full Text] [Related]
27. Multinodular neck recurrence of parotid gland pleomorphic adenoma: a case report.
Papadogeorgakis N; Kalfarentzos EF; Petsinis V; Parara E; Kopaka ME
Oral Maxillofac Surg; 2012 Mar; 16(1):137-40. PubMed ID: 21660435
[TBL] [Abstract][Full Text] [Related]
28. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
Glas AS; Hollema H; Nap RE; Plukker JT
Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
[TBL] [Abstract][Full Text] [Related]
29. CNS metastases of carcinoma ex pleomorphic adenoma of the parotid gland.
Sheedy SP; Welker KM; DeLone DR; Gilbertson JR
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1483-5. PubMed ID: 16908563
[TBL] [Abstract][Full Text] [Related]
30. [Recurrent benign tumors of the parotid gland and their tendency for becoming malignant].
Mann W; Beck C; Karatay MC
Laryngol Rhinol Otol (Stuttg); 1985 Mar; 64(3):133-5. PubMed ID: 2985894
[TBL] [Abstract][Full Text] [Related]
31. Recurrent pleomorphic adenoma: results of surgical treatment.
Makeieff M; Pelliccia P; Letois F; Mercier G; Arnaud S; César C; Garrel R; Crampette L; Guerrier B
Ann Surg Oncol; 2010 Dec; 17(12):3308-13. PubMed ID: 20645014
[TBL] [Abstract][Full Text] [Related]
32. [Clinico-pathological findings of recurrent pleomorphic adenomas of the parotid gland].
Takahashi M; Kumai M; Kamito T; Uehara M; Unno T
Nihon Jibiinkoka Gakkai Kaiho; 1991 Apr; 94(4):489-94. PubMed ID: 1648125
[TBL] [Abstract][Full Text] [Related]
33. The recurrent pleomorphic adenoma conundrum.
Bradley PJ
Curr Opin Otolaryngol Head Neck Surg; 2018 Apr; 26(2):134-141. PubMed ID: 29278551
[TBL] [Abstract][Full Text] [Related]
34. Recurrent pleomorphic adenoma of the parotid.
Fleming WB
Aust N Z J Surg; 1987 Mar; 57(3):173-6. PubMed ID: 3039958
[TBL] [Abstract][Full Text] [Related]
35. Recurrent pleomorphic adenoma of the parotid gland: role of neutron radiation therapy.
Becelli R; Morello R; Renzi G; Matarazzo G; Dominici C
J Craniofac Surg; 2012 Sep; 23(5):e449-50. PubMed ID: 22976702
[TBL] [Abstract][Full Text] [Related]
36. [Problems in diagnosis and therapy of carcinoma in stroma-abundant pleomorphic adenoma of the parotid gland].
Stojadinovic S; Reinert S; Philippou S
Mund Kiefer Gesichtschir; 1998 Sep; 2(5):266-9. PubMed ID: 9816826
[TBL] [Abstract][Full Text] [Related]
37. The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review.
Mc Loughlin L; Gillanders SL; Smith S; Young O
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):283-295. PubMed ID: 30426229
[TBL] [Abstract][Full Text] [Related]
38. Etiology and management of recurrent parotid pleomorphic adenoma.
Witt RL; Eisele DW; Morton RP; Nicolai P; Poorten VV; Zbären P
Laryngoscope; 2015 Apr; 125(4):888-93. PubMed ID: 25289881
[TBL] [Abstract][Full Text] [Related]
39. [Management of recurrent pleomorphic adenoma of the parotid gland: analysis of the material of Otolaryngology Department, Medical University of Warsaw between 1998 and 2008].
Szwedowicz P; Osuch-Wójcikiewicz E; Bruzgielewicz A; Checiński P; Nyckowska J; Grotthuss M
Otolaryngol Pol; 2010 Jun; 64(7):50-4. PubMed ID: 21171312
[TBL] [Abstract][Full Text] [Related]
40. Terminal parotid duct carcinoma.
George MK; Mansour P; Pahor AL
J Laryngol Otol; 1991 Sep; 105(9):780-1. PubMed ID: 1655936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
